Highly-multiplexed imaging by Cyclic Immunofluorescence (CycIF) of protein levels and protein phosphorylation states in the MCF 10A breast cell line treated with EGF or four kinase inhibitors - Dataset (ID:20267)

Proteins Studied

LINCS ID Name HMS LINCS ID UniProt ID Alternative Names Provider Mutation Phosphlorylation State Domain Protein Description
201308 K6B 201308 P04259
Keratin, type II cytoskeletal 6B; Cytokeratin-6B; CK-6B; Keratin-6B; Type-II keratin Kb10
201309 K6C 201309 P48668
Keratin, type II cytoskeletal 6C; Cytokeratin-6C; CK-6C; Cytokeratin-6E; CK-6E; Keratin K6h; Keratin-6C; Type-II keratin Kb12
201310 K8 201310 P05787
Keratin, type II cytoskeletal 8; Cytokeratin-8; CK-8; Type-II keratin Kb8
201296 KI-67 201296 P46013
Antigen KI-67
200537 mTOR 200537 P42345
Serine/threonine-protein kinase mTOR; FK506-binding protein 12-rapamycin complex-associated protein 1; FKBP12-rapamycin complex-associated protein; Mammalian target of rapamycin; Mechanistic target of rapamycin; Rapamycin and FKBP12 target 1; Rapamycin target protein 1
201349 NF-kB p65 201349 Q04206
Transcription factor p65; Nuclear factor NF-kappa-B p65 subunit; Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3
201295 p21 201295 P38936
Cyclin-dependent kinase inhibitor 1; CDK-interacting protein 1; Melanoma differentiation-associated protein 6; MDA-6
201344 p27Kip1 201344 P46527
Cyclin-dependent kinase inhibitor 1B; Cyclin-dependent kinase inhibitor p27
200543 p53 200543 P04637
Cellular tumor antigen p53; Antigen NY-CO-13; Phosphoprotein p53; Tumor suppressor p53
201343 PARP-1 (D214-cleaved) 201343 P09874 D214-cleaved
201302 PCNA 201302 P12004
Proliferating cell nuclear antigen; Cyclin
201335 Rb (pS807) 201335 P06400 pS807
201297 Rb (pS807; pS811) 201297 P06400 pS807; pS811
201336 Rb (pS811) 201336 P06400 pS811
201342 S6 201342 P62753
40S ribosomal protein S6, Phosphoprotein NP33
201298 S6 (pS235; pS236) 201298 P62753 pS235; pS236
201299 S6 (pS240; pS244) 201299 P62753 pS240; pS244
200598 VEGFR-2 200598 P35968
Vascular endothelial growth factor receptor 2; Fetal liver kinase 1; FLK-1; Kinase insert domain receptor; KDR; Protein-tyrosine kinase receptor flk-1; CD309; VEGFR2
201348 Vimentin 201348 P08670